Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/1243
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Murphy, Declan | - |
dc.contributor.other | Maurer, Tobias | - |
dc.contributor.other | Hofman, Michael | - |
dc.contributor.other | Eiber, Matthias | - |
dc.date.accessioned | 2017-09-20T02:45:05Z | - |
dc.date.available | 2017-09-20T02:45:05Z | - |
dc.date.issued | 2017-05 | - |
dc.identifier.citation | Theranostics. 2017 May 15;7(7):2046-2047 | en_US |
dc.identifier.issn | 1838-7640 | en_US |
dc.identifier.uri | http://hdl.handle.net/11434/1243 | - |
dc.description.abstract | Editorial in response to the following study: Jilg CA, Drendel V, Rischke HC, Beck T, Vach W, Schaal K. et al. Diagnostic accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before salvage lymph node dissection for recurrent prostate cancer. Theranostics. 2017;7:1770-80 | en_US |
dc.publisher | Ivyspring International Publisher | en_US |
dc.relation.uri | http://www.thno.org/v07p2046.htm | en_US |
dc.subject | PSMA-PET | en_US |
dc.subject | Lymph Node Detection | en_US |
dc.subject | Lymph Nodes | en_US |
dc.subject | Recurrent Prostate Cancer | en_US |
dc.subject | Prostate Cancer | en_US |
dc.subject | Magic Bullet | en_US |
dc.subject | Imaging | en_US |
dc.subject | Positron Emission Tomography | en_US |
dc.subject | PET | en_US |
dc.subject | Computed Tomography | en_US |
dc.subject | CT | en_US |
dc.subject | Magnetic Resonance Imaging | en_US |
dc.subject | MRI | en_US |
dc.subject | Prostate-Specific Membrane Antigen | en_US |
dc.subject | PSMA | en_US |
dc.subject | Lymph Node Metastases | en_US |
dc.subject | Australian Prostate Cancer Research Centre Epworth HealthCare, Victoria, Australia | en_US |
dc.title | PSMA-PET for lymph node detection in recurrent prostate cancer: how do we use the magic bullet? | en_US |
dc.type | Letter | en_US |
dc.rights.holder | Ivyspring International Publisher | en_US |
dc.identifier.doi | 10.7150/thno.20855 | en_US |
dc.identifier.journaltitle | Theranostics | en_US |
dc.description.pubmeduri | https://www.ncbi.nlm.nih.gov/pubmed/28638485 | en_US |
dc.description.affiliates | Department of Urology, Technical University of Munich, Munich, Germany. | en_US |
dc.description.affiliates | Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia | en_US |
dc.description.affiliates | The Sir Peter MacCallum Department of Oncology, University of Melbourne | en_US |
dc.description.affiliates | Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia | en_US |
dc.description.affiliates | Department of Nuclear Medicine, Technical University of Munich, Munich, Germany | en_US |
dc.description.affiliates | Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Cancer Services Epworth Prostate Centre |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Maurer et al 2017.pdf | 185.58 kB | Adobe PDF | View/Open |
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.